gi-101
Showing 1 - 1 of 1
Advanced Solid Tumor, Metastatic Solid Tumor, NSCLC Trial in Suwon-si, Daejeon, Seoul (GI-101, Pembrolizumab, Lenvatinib)
Recruiting
- Advanced Solid Tumor
- +7 more
- GI-101
- +3 more
-
Suwon-si, Kyeonggi-do, Korea, Republic of
- +3 more
Apr 19, 2022